El 26 de enero a las 17h se llevó a cabo en el ciclo de charlas de la Cátedra SAMCA de Nanotecnología  “Thursday´s NanoSpin-off Talks”, la charla “Nanotechnology in the era of personalized medicine: advancing the path of molecular therapeutics from lab to market”

DIVERSA is a biotechnology company established in 2022 as a spin-off from the Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS). DIVERSA promotes the transfer to the clinic of new therapeutic molecules through the application of drug delivery nanotechnology. Our technology is based on patented, non-toxic, biodegradable lipid nanoemulsions to improve patients’ lives

Publicado en General, Nano Spin-Off, Transferencia y etiquetado: